Post-Test Below-The-Knee Implants and Dissection Repair: A Review of Current Applications and New Data Post-Test This is attempt (1/3) Grade C-F dissections occur how often post-PTA (percutaneous transluminal angioplasty)? Less than 50% More than 50% Less than 35% About 45% In BTK procedures with drug-coated balloons and real-world lesions, mechanical support: Is not needed Is needed Makes no difference for procedures Isn’t safe Each of the following is a predictor of dissection except: Lesion length CTO (chronic total occlusions) Lesion circumference Calcification Chronic Limb-Threatening Ischemia afflicts how many people in the United States? 2–3.4 million 1-1.5 million 500,000 4 million The 12-month results of the TOBA II BTK Tack implant study revealed all of the following except: No fracture, migration, or embolization 81.3% K-M Tacked segment patency 83.1% K-M freedom from CD-TLR No improvement in Rutherford, TBI and QoL Tack Endovascular System is the first BTK vascular implant to achieve FDA approval? True False A 2019 study of the Tack Endovascular System for infrainguinal dissection repair in a real-world setting concluded that treatment with Tack implants: Resolved a majority of dissections at 98.3% Resolved few dissections at 13.8% Resolved half of the dissections at 50% Resolved no dissections According to the 2019 Tack implant study, which of the following improved technical outcome: lesion preparation therapy (atherectomy, lithoplasty) fewer comorbidities patients’ age nothing helped improve outcome The 2019 Tack implant study showed that major adverse advents and device-related complications: occurred frequently occurred in half the patients did not occur at all What can potentially compromise a lower extremity revascularization procedure? distal tacks flow-limiting distal dissection restoring peroneal and anterior continuation flow through the arch Previous
